MedPath

Low Flow Low Gradient Aortic Stenosis Relevance of the (re)Search for a Contractile Reserve

Completed
Conditions
Aortic Valve Stenosis
Registration Number
NCT02727504
Lead Sponsor
Rennes University Hospital
Brief Summary

Investigators sought to demonstrate that the increase in the stroke volume during a dobutamine stress echocardiography might impact the prognosis of a patient addressed for a low flow low gradient suspected severe aortic valve stenosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
86
Inclusion Criteria
  • Patient from 45 to 90 years old
  • Patient agreeing freely to participate in the study
  • Aortic surface area suspected to be < 1 cm² or < 0.6 cms²/m²
  • Low aortic gradient defined by a mean pressure gradient < 40 mmHg
  • Aortic low flow defined by: a stroke volume indexed < 35 ml/m2
  • Any contra-indication for the realization of the MRI
Exclusion Criteria
  • Heart rhythm disorders
  • Presence of comorbidity altering the 2-year prognosis of a patient (cancer, terminal renal insufficiency (GFR 30 ml / min / 1,73m2), liver cirrhosis, respiratory insufficiency (VEMS 1 L)
  • Presence of a concomitant valvular heart disease with stenosis or regurgitation > moderated
  • Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of death of all causeMonth 12
Number of emergent hospitalization for any cardiovascular reasonMonth 12
Secondary Outcome Measures
NameTimeMethod
Death (all causes)12 months
Emergency Cardiovascular hospitalization12 months
Change in left ventricular ejection fraction (LVEF), in global longitudinal strain in 2D and or 3D echocardiographyInclusion, 12 months
Symptoms evolutionInclusion, 12 months

Duke Activity Score

Trial Locations

Locations (1)

CHU de Rennes

🇫🇷

Rennes, France

CHU de Rennes
🇫🇷Rennes, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.